﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>Advances in Pharmacological Sciences</title><link>http://www.hindawi.com</link><description>The latest articles from Hindawi Publishing Corporation</description><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright><item><title>Distinct Effects of Contraction Agonists on the Phosphorylation State of Cofilin in Pulmonary Artery Smooth Muscle</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/362741</link><description>We hypothesized that agonist-induced contraction correlates with the phospho-cofilin/cofilin (P-CF/CF) ratio in pulmonary artery (PA) rings and cultured smooth muscle cells (PASMCs). PA rings were used for isometric contractions and along with PASMCs for assay of P-CF/CF by isoelectric focusing and immunoblotting. The P-CF/CF measured 22.5&amp;#x25; in PA and differentiated PASMCs, but only 14.8&amp;#x25; in undifferentiated PASMCs. With comparable contraction responses in PA, endothelin-1 (100&amp;#x2009;nM) and norepinephrine (1&amp;#x2009;&amp;#x03BC;M) induced a 2-fold increase of P-CF/CF, while angiotensin II (1&amp;#x2009;&amp;#x03BC;M) induced none. All agonists activated Rho-kinase and LIMK2, and activation was eliminated by inhibition of Rho-kinase. Microcystin LF (20&amp;#x2009;nM) potentiated the angiotensin II, but not the 5-hydroxytryptamine (1&amp;#x2009;&amp;#x03BC;M)-mediated increase of P-CF/CF. In conclusion, all tested agonists activate the Rho-kinase-LIMK pathway and increase P-CF/CF. Angiotensin II activates PP2A and counteracts the LIMK-mediated CF phosphorylation. CF phosphorylation stabilizes peripheral actin structures and may contribute to the maximal contraction of PA.</description><Author>Yan-Ping Dai, Shaner Bongalon, Violeta N. Mutafova-Yambolieva, and Ilia A. Yamboliev</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item></channel></rss>